Health Care & Life Sciences » Biotechnology | Revance Therapeutics Inc.

Revance Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
617.00
383.00
300.00
300.00
262.00
3,729
Cost of Goods Sold (COGS) incl. D&A
1,881.00
-
1,995.00
-
-
-
Gross Income
1,264.00
-
1,695.00
-
-
-
SG&A Expense
36,961.00
50,382.00
70,622.00
78,011.00
116,291.00
144,637
EBIT
38,225.00
52,050.00
72,317.00
79,156.00
117,497.00
142,634
Unusual Expense
1,343.00
6,980.00
127.00
9,667.00
3,518.00
140
Non Operating Income/Expense
404.00
1,590.00
327.00
535.00
525.00
773
Interest Expense
15,164.00
2,341.00
1,190.00
1,082.00
457.00
44
Pretax Income
52,448.00
62,917.00
73,476.00
89,270.00
120,587.00
139,568
Consolidated Net Income
258.00
62,917.00
73,476.00
89,270.00
120,587.00
142,568
Net Income
258.00
62,917.00
73,476.00
89,270.00
120,587.00
142,568
Net Income After Extraordinaries
258.00
62,917.00
73,476.00
89,270.00
120,587.00
142,568
Net Income Available to Common
258.00
62,917.00
73,476.00
89,270.00
120,587.00
142,568
EPS (Basic)
1.05
3.24
3.02
3.18
4.01
3.94
Basic Shares Outstanding
22,653.30
19,391.50
24,340.50
28,114.80
30,101.10
36,171.60
EPS (Diluted)
0.05
3.24
3.02
3.18
4.01
3.94
Diluted Shares Outstanding
22,653.30
19,391.50
24,340.50
28,114.80
30,101.10
36,171.60
EBITDA
36,344.00
49,999.00
70,322.00
77,711.00
116,029.00
140,908
Non-Operating Interest Income
2.00
44.00
231.00
1,170.00
1,410.00
4,023
Other After Tax Income (Expense)
52,706.00
-
-
-
-
-

About Revance Therapeutics

View Profile
Address
7555 Gateway Boulevard
Newark California 94560
United States
Employees -
Website http://www.revance.com
Updated 07/08/2019
Revance Therapeutics, Inc. is a clinical stage biopharmaceutical company. It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic, and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for a broad spectrum of aesthetic and therapeutic indications, including facial wrinkles and muscle movement disorders.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.